Liver Disease

Have you been told that you have fatty liver or NASH?

This is a Phase 2 clinical research study designed to examine the effect of an investigational drug in patients with fatty liver disease, more specifically patients with NASH and some evidence of liver scarring or liver fibrosis.

To qualify you must have:

  • At least 2 of the following: Type 2 diabetes, obesity, high blood pressure, elevated liver enzymes
  • At least 18 years of age
  • NASH or non-alcoholic steatohepatitis

If you qualify, you will receive study related:

  • Medication
  • Diagnostic procedures
  • Physical Exams
  • Laboratory tests
  • Compensation for time and travel

Are you suffering from NASH (Nonalcoholic steatohepatitis)?

We are looking for volunteers with biopsy-proven NASH verified by pathology reading, to evaluate the safety and efficacy of 2 oral doses of an investigational medicine in reducing liver fat.

Qualified participants will receive at no cost:

  • Study-related medication
  • Study-related laboratory testing
  • Study-related ECGs and physical examinations
  • Physician oversight of medical care
  • Compensation for your time and travel

Study length: Approximately 32 weeks